The pharmaceutical industry’s pursuit of advanced drug delivery systems necessitates the use of high-performance excipients. Methacrylic Acid - Ethyl Acrylate Copolymer (1:1), Type A, commonly identified by its product designation MAE 100-55, is a prime example of such an excipient, widely utilized for its exceptional film-forming and enteric release properties. NINGBO INNO PHARMCHEM CO.,LTD. is a trusted provider of this critical material, ensuring its availability for pharmaceutical innovators worldwide.

At its core, MAE 100-55 is a synthetic polymer derived from methacrylic acid and ethyl acrylate. Its precise composition is designed to yield specific functionalities crucial for pharmaceutical coatings. A key characteristic is its weakly acidic nature and its solubility profile, which dictates its performance in enteric coating applications. Unlike many other enteric polymers, MAE 100-55 begins to dissolve at a pH above 5.5, making it suitable for formulations targeting specific regions of the gastrointestinal tract. This precise pH-dependent dissolution is vital for protecting sensitive APIs from gastric degradation and ensuring their release in the more alkaline environment of the small intestine. When a manufacturer decides to buy this product, they are opting for controlled release capabilities.

From a manufacturing perspective, the physical attributes of MAE 100-55 offer significant advantages. It is supplied as a white or off-white solid powder that is largely dust-free. This attribute is highly valued in pharmaceutical manufacturing environments. Reduced dust generation leads to improved workplace safety by minimizing inhalation risks for personnel. It also contributes to higher material yield and more uniform coating application, which is essential for consistent drug release profiles. NINGBO INNO PHARMCHEM CO.,LTD. prioritizes the supply of such refined materials to meet industry demands for both efficacy and efficiency when clients purchase from us.

The adherence to stringent quality standards is non-negotiable in the pharmaceutical sector. MAE 100-55 from NINGBO INNO PHARMCHEM CO.,LTD. is produced to meet or exceed the requirements of major pharmacopeias, including USP-NF, EP, and JPE. This includes critical parameters such as appearance, identification, clarity of solution, pH, average molecular weight, and low levels of impurities like ash and heavy metals. The inclusion of stabilizers like BHT is also controlled within specified limits. Such rigorous quality control ensures that this high purity pharmaceutical coating polymer consistently delivers the expected performance, supporting the development of safe and effective drug products.

In conclusion, Methacrylic Acid - Ethyl Acrylate Copolymer MAE 100-55 is an indispensable excipient for advanced pharmaceutical coatings, particularly for enteric release applications. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing this high-quality, dust-free material, enabling pharmaceutical companies to optimize their formulations and manufacturing processes. For those looking to purchase a superior enteric coating agent that adheres to global standards, MAE 100-55 is an excellent choice, reflecting a dedication to innovation and excellence in pharmaceutical raw materials.